top of page

About Us

We are dedicated neuroscientists and drug delivery experts.

We are focused on addressing major therapeutic challenges in the brain and bringing hope to patients with neurological disorders through innovative RNA therapies.

Untitled.png
Mask group-1.png

Louis-Phillippe Bernier, PhD

Chief Executive Officer & Co-Founder

Accomplished academic neuroscientist turned biotech entrepreneur developing next-generation treatments to transform the lives of patients with neurological disease.

Mask group-2.png

Nicholas Weilinger, PhD

Chief Scientific Officer & Co-Founder

Translational neuroscientist with expertise in neurodegeneration and stroke, with a proven track record of characterizing novel therapeutic targets in the brain.

Mask group-4.png

Richard Howlet, PhD

Chief Business Officer & Co-Founder

Industry veteran with senior business development experience spanning small biotech to large pharma. He is focused on driving growth and value creation through strategic partnerships.

Mask group.png

Brian MacVicar, PhD, FRSC

Co-Founder & Board Chair

Internationally renowned neuroscientist with over 200 publications on his groundbreaking discoveries uncovering the pathological basis of brain disorders.

Mask group-3.png

Pieter Cullis, PhD, OC, FRSC

Co-Founder & Director

A world leader in nanomedicine therapeutics. His pioneering work on lipid nanoparticles was instrumental in developing FDA-approved drugs Onpattro® and Comirnaty®.

Leadership Team

About Page_no_exit.png
Untitled.png

Partner with us and
be part of the change

bottom of page